Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]
Main Authors: | , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-03-01
|
Series: | Heliyon |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405844019321991 |
id |
doaj-b9d5013a4fb94e94b8365246538943d0 |
---|---|
record_format |
Article |
spelling |
doaj-b9d5013a4fb94e94b8365246538943d02020-11-25T02:54:55ZengElsevierHeliyon2405-84402019-03-0153e01309Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039]Xiaosheng Wu0Yanli Li1Xin Liu2Chunhua Chen3Susan M. Harrington4Siyu Cao5Tiancheng Xie6Tu Pham7Aaron S. Mansfield8Yiyi Yan9Eugene D. Kwon10Liewei Wang11Kun Ling12Haidong Dong13Department of Medicine Division of Hematology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USADivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USADivision of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Biochemistry and Molecular Biology, Mayo Clinic College of Medicine, Rochester, MN, USADepartment of Urology, Mayo Clinic College of Medicine, Rochester, MN, USA; Department of Immunology, Mayo Clinic College of Medicine, Rochester, MN, USA; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2405844019321991 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xiaosheng Wu Yanli Li Xin Liu Chunhua Chen Susan M. Harrington Siyu Cao Tiancheng Xie Tu Pham Aaron S. Mansfield Yiyi Yan Eugene D. Kwon Liewei Wang Kun Ling Haidong Dong |
spellingShingle |
Xiaosheng Wu Yanli Li Xin Liu Chunhua Chen Susan M. Harrington Siyu Cao Tiancheng Xie Tu Pham Aaron S. Mansfield Yiyi Yan Eugene D. Kwon Liewei Wang Kun Ling Haidong Dong Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] Heliyon |
author_facet |
Xiaosheng Wu Yanli Li Xin Liu Chunhua Chen Susan M. Harrington Siyu Cao Tiancheng Xie Tu Pham Aaron S. Mansfield Yiyi Yan Eugene D. Kwon Liewei Wang Kun Ling Haidong Dong |
author_sort |
Xiaosheng Wu |
title |
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] |
title_short |
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] |
title_full |
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] |
title_fullStr |
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] |
title_full_unstemmed |
Corrigendum to “Targeting B7-H1 (PD-L1) sensitizes cancer cells to chemotherapy” [Heliyon 4 (12) (December 2018) e01039] |
title_sort |
corrigendum to “targeting b7-h1 (pd-l1) sensitizes cancer cells to chemotherapy” [heliyon 4 (12) (december 2018) e01039] |
publisher |
Elsevier |
series |
Heliyon |
issn |
2405-8440 |
publishDate |
2019-03-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2405844019321991 |
work_keys_str_mv |
AT xiaoshengwu corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT yanlili corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT xinliu corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT chunhuachen corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT susanmharrington corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT siyucao corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT tianchengxie corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT tupham corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT aaronsmansfield corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT yiyiyan corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT eugenedkwon corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT lieweiwang corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT kunling corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 AT haidongdong corrigendumtotargetingb7h1pdl1sensitizescancercellstochemotherapyheliyon412december2018e01039 |
_version_ |
1724718934419046400 |